An observational study performed among 303 participants with and without T2DM who underwent computed tomography (CT) angiography due to chest pain, reported a positive association of endogenous GLP-1 levels with coronary plaque burden ( In addition to direct actions in coronary arteries, GLP-1 RAs can prevent the formation and progression of coronary atherosclerosis through indirect mechanisms, such as maintaining glycemic control, losing weight, decreasing systolic blood pressure, obtaining beneficial effects from lipid levels, inhibiting platelet activation, reducing systemic inflammation and levels of circulating BNP ( Glucagon-Like Peptide 1 Receptor Agonists and Vasospasm of Epicardial Coronary Arteries Spasms in the smooth muscle layer of the coronary artery wall can be focal or diffuse, resulting in vasospastic angina or myocardial infarction (MI), respectively
Even at retail pharmaceutical pricing, Retatrutides superior efficacy provides better value than Semaglutide
Women with PCOS, perimenopause, or insulin resistance Patients with GI sensitivity or history of medication intolerance Individuals seeking metabolic or hormonal balance without rapid weight loss Patients who want to layer GLP-1s with lifestyle changes, not use them as a crutch Is Microdosing Less Effective
Over weeks of daily or weekly injections, those errors compound significantly
